Abstract: A voice activity detection device includes an audio processing circuit, a first memory, and a processor. The audio processing circuit processes an audio signal from an audio generator circuit to generate first audio data. The first memory stores the first audio data and a first program code. The processor executes the first program code to operate in a first mode, and is switched from operating in the first mode to operating in a second mode in response to an interrupt signal from the audio generator circuit, in order to determine whether the first audio data stored in the first memory includes a human voice signal, wherein power consumption of the processor operating in the first mode is lower than that in the second mode.

Abstract: The disclosure provides for compounds and methods for modulating or inhibiting TEAD. Further provided herein are pharmaceutical compositions comprising the TEAD inhibitors and methods of treatment using the TEAD inhibitors or the pharmaceutical compositions.

Abstract: Described herein are DGKalpha inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with DGKalpha.

Abstract: A semiconductor structure and a formation method therefor. The semiconductor structure comprises: a substrate, which has opposite first and second surfaces, and comprises several discrete active areas arranged in a first direction and parallel to a second direction, wherein the first direction is perpendicular to the second direction; word line gate structures, which are disposed in the active areas, extend from the first surface to the second surface, are arranged in the second direction, and run through the active areas along the first direction; a first isolation structure, which is disposed in the substrate and extends from the second surface to the first surface; bit line structures, which are disposed on the first surface, electrically coupled with the active areas, arranged in the first direction, and parallel to the second direction; and capacitor structures, which are disposed on the second surface and electrically coupled with the active areas.

Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.

Abstract: Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.

Abstract: Embodiments of the disclosure provide a method for manufacturing a memory device, the method includes operations. At least one cell block is formed on a wafer, each of the at least one cell block includes multiple memory cells distributed in an array, each of the multiple memory cells includes a transistor and a storage capacitor connected to a source of the transistor. Bit lines are formed on the wafer, and each of the bit lines is connected to a drain of the transistor, here each of the bit lines and the storage capacitor are located on opposite surfaces of the wafer in a thickness direction respectively. A peripheral circuit is formed above the bit lines on the wafer along a perpendicular of the wafer, here the peripheral circuit includes at least a Sensing Amplifier (SA). An electrical connection is formed between the bit line and the SA.

Abstract: Described herein are MAT2A inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with MAT2A.

Abstract: The disclosure provides for compounds and methods for modulating or inhibiting TEAD. Further provided herein are pharmaceutical compositions comprising the TEAD inhibitors and methods of treatment using the TEAD inhibitors or the pharmaceutical compositions.

Abstract: Described herein are MAT2A inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with MAT2A.

Abstract: The present invention discloses a video processing circuit, which is coupled to a memory chip and includes an image processing circuit. The image processing circuit includes a first channel, a second channel and a compression circuit. The two channels process first image data and second image data to generate first processed image data and second processed image data, respectively. The compression circuit compresses the first processed image data and the second processed image data to generate first compressed image data and second compressed image data, respectively. A memory block in the memory chip is configured as a ring buffer shared by the first channel and the second channel so as to store the first compressed image data and the second compressed image data.

Abstract: Described herein are DGKalpha inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with DGKalpha.

Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.

Abstract: Described herein are DGKalpha inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with DGKalpha.

Abstract: Provided herein are compounds, pharmaceutical compositions, and methods for treating a SARS-CoV-2 infection.

Abstract: Aspects of the present disclosure address systems and methods for driver resizing using a transition-based capacitance increase margin. An integrated circuit (IC) design stored in a database in memory is accessed. The IC design comprises a net comprising a set of driver cells. A capacitance increase margin for resizing an initial driver cell is determined based on a total capacitance of the net and transition time target associated with the initial driver cell. An alternative driver cell is selected from a library to resize the initial driver cell and is used to replace the initial driver cell in the net. The alternative driver is selected such that a pin capacitance of the alternative driver cell exceeds an initial pin capacitance corresponding to the initial driver cell by no more than the capacitance increase margin.

Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.

Abstract: The present disclosure provides a use of a novel environment-friendly agricultural chemical, and belongs to the field of agricultural chemicals. It is found in the present disclosure that methyl 4-hydroxyphenylacetate may be used for controlling plants and preparing herbicides. The methyl 4-hydroxyphenylacetate in the present disclosure has a use concentration greater than 150 mmol/L. The herbicide is prepared by using the methyl 4-hydroxyphenylacetate as an active ingredient in the present disclosure has a good controlling and killing effect on perennial herbs or Half-shrubby plants, especially Eupatorium adenophorum, and has low toxicity, no harm, and no solvent residues after use.

Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.

Abstract: The disclosure relates to the field of electric vehicles, and in particular provides a vehicle refrigerator control method, a storage medium, and a vehicle, aiming to solve the problems of how to implement the intelligent identification of items stored in a vehicle refrigerator, and of controlling the vehicle refrigerator based on information of the stored item and vehicle state information. To this end, the method of the disclosure includes: obtaining item information of a vehicle refrigerator; obtaining a real-time temperature and a target temperature of the vehicle refrigerator; obtaining vehicle state information; and controlling the vehicle refrigerator based on the real-time temperature, the target temperature, and the vehicle state information.